BNP Paribas trims RBL Bank stake through bulk deal as BofA buys in, even as the lender posts strong profits, healthier asset quality, and long-term stock gains. French multinational bank BNP Paribas ...

The Competition Commission of India (CCI) has approved Emirates NBD Bank’s proposal to acquire a majority stake in RBL Bank. Under the proposed deal, Emirates NBD Bank plans to acquire between 51% and ...

RBL Bank (RBK) reported a 3QFY26 PAT of INR2.1b (20% miss, up 20% QoQ) amid higher-than-expected provisions, partly offset by better other income. NII stood better at 4.6% YoY/6.9% QoQ, reaching INR16 ...

The Competition Commission of India on Tuesday approved the proposed acquisition of majority shareholding in RBL Bank Ltd. by Emirates NBD Bank. The Dubai-based lender had announced a $3 billion deal ...

RBL Bank Q3 earnings: The private lender reported a net profit of ₹214 crore for the October to December 2025 quarter, which was impacted by one-off pre-tax expenses of ₹32 crore. Speaking on the RBL ...

Shares of RBL Bank Ltd., the Mumbai-based private lender are trading with losses of over 7% on Monday, January 19. This is the biggest single-day drop for the stock since June 2024. Shares are ...

Digital banking firm PT Super Bank Indonesia surged 24%, hitting the daily trading limit, on its Jakarta debut following an initial public offering that ranks as Indonesia’s second largest this year.

DALLAS--(BUSINESS WIRE)--Matador Resources Company (NYSE: MTDR) (“Matador”) is pleased to announce (i) the successful, unanimous redetermination of the borrowing base under Matador’s reserves-based ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

ROCKVILLE, Md., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of ...